Profil
Paul van Slyke served as the Chief Scientific Officer at Vasomune Therapeutics, Inc. and Sairiyo Therapeutics, Inc. He also held the position of Chief Scientific Officer at Pharmadrug, Inc. from 2021 to 2023.
Dr. van Slyke obtained a doctorate degree from the University of Toronto.
Anciens postes connus de Paul van Slyke
| Sociétés | Poste | Fin |
|---|---|---|
| PHARMADRUG INC. | Directeur Technique/Scientifique/R&D | 01/05/2023 |
Sairiyo Therapeutics, Inc.
 Sairiyo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Pharmadrug, Inc., Sairiyo Therapeutics, Inc. is a Canadian company that manufactures and sells pharmaceutical products. Sairiyo Therapeutics was acquired by Pharmadrug, Inc. | Directeur Technique/Scientifique/R&D | - |
Vasomune Therapeutics, Inc.
 Vasomune Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Vasomune Therapeutics, Inc. operates as an early stage biopharmaceutical company. It develops medicines to harness the body’s ability to defend against illness by modifying cellular response to disease. The company is headquartered in Toronto, Canada. | Directeur Technique/Scientifique/R&D | - |
Formation de Paul van Slyke
| University of Toronto | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PHARMADRUG INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Sairiyo Therapeutics, Inc.
Sairiyo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Pharmadrug, Inc., Sairiyo Therapeutics, Inc. is a Canadian company that manufactures and sells pharmaceutical products. Sairiyo Therapeutics was acquired by Pharmadrug, Inc. | Health Technology |
Vasomune Therapeutics, Inc.
Vasomune Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Vasomune Therapeutics, Inc. operates as an early stage biopharmaceutical company. It develops medicines to harness the body’s ability to defend against illness by modifying cellular response to disease. The company is headquartered in Toronto, Canada. | Health Technology |
